The fast-growing global wearable electrocardiogram (ECG) devices market offers exciting growth opportunities for competitors.

With more than 81 million COVID-19 cases and 1.7 million deaths worldwide as of December 2020, as per the World Health Organization (WHO), the COVID-19 pandemic continues to be an ongoing problem and is expected to have a long-term impact on home healthcare products.

GMR Data forecasts that China's medical devices market will reach $218.2 billion in 2030, up from $92.8 billion in 2020, as Chinese pharmaceutical markets continue their growth trajectory.

As obesity rates climb and Americans age, more people are developing sleep apnea, restless leg syndrome and other sleep disorders. Plus, stress in 2020 related to the presidential election, Covid-19 pandemic and recession are all contributing to more sleepless nights.

The COVID-19 pandemic has prompted the healthcare industry to expand its use of telemedicine — services that provide healthcare to people at a distance with the help of communication technology.

Ventilators offer critical care support to patients who are unable to breathe on their own. The recently discovered novel coronavirus strain, also known as COVID-19, has led to a rapid rate of respiratory infections and deaths globally. Therefore, a dramatic rise in the demand for ventilators is currently being witnessed, owing to the severe respiratory illness caused by the disease.

To help prevent the spread of COVID-19, a wide array of healthcare organizations, businesses, and consumers have scrambled to obtain items they once took for granted or had little need for: personal protective equipment (PPE), including disposable masks, face shields, and medical gloves.

The global respiratory masks (N95 respirators, surgical masks, and others) market will grow from 14,600 million units in 2019 to 33,360.9 million units in 2023 at a compound annual growth rate (CAGR) of 22.9%, according the Respiratory Masks Global Market Opportunities And Strategies To 2030 report by The Business Research Company.

The global patient monitoring devices market is expected to grow from $22.4 billion in 2018 to $30.7 billion in 2022 at an annual growth rate of more than 8%.

The global market for insulin monitoring wearable medical devices is set to increase by over 20% year on year to 2022. The segment is the largest of the therapeutic wearable medical devices market, well ahead of pain management, respiratory therapy and rehabilitation devices. All these segments are, however, growing at close to 20% a year.